Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 56.64 USD 2.39% Market Closed
Market Cap: 3.5B USD

Relative Value

The Relative Value of one PTGX stock under the Base Case scenario is 15.64 USD. Compared to the current market price of 56.64 USD, Protagonist Therapeutics Inc is Overvalued by 72%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PTGX Relative Value
Base Case
15.64 USD
Overvaluation 72%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
50
vs Industry
51
Median 3Y
8.8
Median 5Y
20.2
Industry
7.5
Forward
42.3
vs History
0
vs Industry
10
Median 3Y
-3.2
Median 5Y
-7.6
Industry
23.6
Forward
-28.6
vs History
11
vs Industry
10
Median 3Y
-4.2
Median 5Y
-9.6
Industry
20.2
vs History
11
vs Industry
9
Median 3Y
-4.2
Median 5Y
-9.5
Industry
22.9
vs History
20
vs Industry
20
Median 3Y
3.7
Median 5Y
4.1
Industry
2.8
vs History
49
vs Industry
45
Median 3Y
4.7
Median 5Y
13
Industry
7.7
Forward
35.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
0
vs Industry
11
Median 3Y
-0.9
Median 5Y
-4.9
Industry
4.9
Forward
-20
vs History
0
vs Industry
10
Median 3Y
-0.9
Median 5Y
-4.9
Industry
4.9
Forward
-22
vs History
9
vs Industry
11
Median 3Y
-1.5
Median 5Y
-6.6
Industry
5.4
vs History
9
vs Industry
8
Median 3Y
-1.4
Median 5Y
-6.6
Industry
4
vs History
63
vs Industry
22
Median 3Y
16.5
Median 5Y
32.3
Industry
5.1

Multiples Across Competitors

PTGX Competitors Multiples
Protagonist Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Protagonist Therapeutics Inc
NASDAQ:PTGX
3.5B USD 16.9 62.4 95.6 107.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 182 884.2 -162 466.2 -197 285.8 -195 034.5
US
Abbvie Inc
NYSE:ABBV
336.6B USD 5.9 81 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
160.8B USD 4.7 27.1 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
136.8B USD 4.8 22.9 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD 10.9 -122 26 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 060.9 -525.9 -572.7 -557.4
AU
CSL Ltd
ASX:CSL
120.3B AUD 5.2 28.6 17.6 22
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.3B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD 17.9 -156 -699.8 -350.7
P/E Multiple
Earnings Growth PEG
US
Protagonist Therapeutics Inc
NASDAQ:PTGX
Average P/E: 39.2
62.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 466.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.9
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.6
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Protagonist Therapeutics Inc
NASDAQ:PTGX
Average EV/EBITDA: 27.3
95.6
-37%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 285.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.6
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Protagonist Therapeutics Inc
NASDAQ:PTGX
Average EV/EBIT: 33
107.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 034.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.4 N/A N/A
AU
CSL Ltd
ASX:CSL
22
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.7 N/A N/A